CW30467

General

Cell Line

hPSCreg Name
CIRMi04F-A
Alternative name(s)
CW30467
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
ICANi001-A-1
(CDGEN1.16.40.5)
Donor diseases:
hypertrophic cardiomyopathy
UKEi070-A-1
(Rep 28, Iso Co)
Donor diseases:
hypertrophic cardiomyopathy
UKEi070-A-2
(Bi-allelic mutant, Mut 103)
Donor diseases:
hypertrophic cardiomyopathy
CIRMi929-A
(CW30245)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi965-A
(CW30288)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi00O-A
(CW30346)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi01B-A
(CW30362)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi726-A
(CW30001)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi731-A
(CW30006)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi736-A
(CW30011)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi741-A
(CW30017)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi742-A
(CW30018)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi744-A
(CW30020)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi752-A
(CW30032)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi770-A
(CW30054)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi771-A
(CW30055)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi779-A
(CW30064)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi781-A
(CW30067)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi793-A
(CW30080)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi797-A
(CW30084)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi823-A
(CW30115)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi835-A
(CW30133)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi838-A
(CW30139)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi850-A
(CW30155)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi865-A
(CW30172)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi869-A
(CW30177)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi893-A
(CW30205)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi909-A
(CW30224)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi919-A
(CW30234)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi920-A
(CW30235)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi937-A
(CW30256)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi947-A
(CW30266)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi969-A
(CW30292)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi970-A
(CW30293)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi971-A
(CW30295)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi982-A
(CW30310)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi983-A
(CW30311)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi984-A
(CW30312)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi985-A
(CW30314)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi999-A
(CW30329)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi00A-A
(CW30331)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi00J-A
(CW30340)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi00M-A
(CW30344)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi00N-A
(CW30345)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi00T-A
(CW30354)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi01D-A
(CW30364)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi01O-A
(CW30389)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi01P-A
(CW30390)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi01S-A
(CW30393)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi01V-A
(CW30397)
Donor diseases:
Hypertrophic Cardiomyopathy
Last update 27th September 2023
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator California Institute for Regenerative Medicine (CIRM)
Owner California Institute for Regenerative Medicine (CIRM)
Distributors
Derivation country United States

External Databases

BioSamples SAMEA114429961
CLO CLO_0105163

General Information

* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: allowed

Donor Information

General Donor Information

Sex female
Age of donor (at collection) 60-64

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
Hypertrophic Cardiomyopathy
HYPERTROPHIC CARDIOMYOPATHY
Synonyms
  • Hypertrophic Cardiomyopathy

External Databases (Donor)

BioSamples SAMEA114429962

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? No
Provide contact information of the holder of the original Donor Information Sheet: info@cirm.ca.gov
Do you (Depositor/Provider) hold the original Donor Consent Form? No
If you do not hold the Donor Consent Form, do you know who does? Yes
Contact information / weblink info@cirm.ca.gov
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. pseudonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No
How may genetic information associated with the cell line be accessed? Controlled Access
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? Stanford University
Approval number eprotocol 27773
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the PROPOSED PROJECT, involving use of donated embryo/tissue or derived cells? Yes
Name of accrediting authority involved? Stanford University
Approval number eprotocol 27773
Is there an MTA available for the cell line? Yes

hIPSC Derivation

General

Source cell type
blood cell
A cell found predominately in the blood.
Age of donor (at collection) 60-64

Reprogramming method

Vector type Non-integrating
Vector Episomal
Is reprogramming vector detectable?
No

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Medium Essential 8™

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR FACS Enzymatic Assay Expression Profiles
POU5F1 (OCT-4)
Yes
NANOG
Yes
Lin28
Yes
Lin28
Yes
Undifferentiated cells were analyzed by proprietary assays approved by California Institute of Regenerative Medicine (CIRM) as described in the attached publication. Pluripotency of established iPSC cultures were tested by qPCR on bulk samples using 48 genes including standard pluripotency genes (listed above). Samples were assigned a passing score after analysis with a non-supervised classifier based on an appropriate sample set. (Novak, T. 2015. Drug Discovery World pp. 47-53.)
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
Mesoderm
Ont Id: UBERON_0000926
Ectoderm
Ont Id: UBERON_0000924

Microbiology / Virus Screening

HIV 1 Negative
HIV 2 Negative
Hepatitis B Negative
Hepatitis C Negative
Mycoplasma Negative

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
Normal

Other Genotyping (Cell Line)